HUTCHMED (China) (HCM) Common Equity (2016 - 2025)
HUTCHMED (China) has reported Common Equity over the past 12 years, most recently at $1.3 billion for Q4 2025.
- Quarterly Common Equity rose 62.11% to $1.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Dec 2025, up 62.11% year-over-year, with the annual reading at $1.3 billion for FY2025, 62.11% up from the prior year.
- Common Equity was $1.3 billion for Q4 2025 at HUTCHMED (China), up from $771.9 million in the prior quarter.
- Over five years, Common Equity peaked at $1.3 billion in Q4 2025 and troughed at $636.9 million in Q4 2022.
- The 5-year median for Common Equity is $771.9 million (2024), against an average of $888.6 million.
- Year-over-year, Common Equity skyrocketed 100.31% in 2021 and then plummeted 38.73% in 2022.
- A 5-year view of Common Equity shows it stood at $1.0 billion in 2021, then crashed by 38.73% to $636.9 million in 2022, then grew by 16.73% to $743.4 million in 2023, then increased by 3.83% to $771.9 million in 2024, then skyrocketed by 62.11% to $1.3 billion in 2025.
- Per Business Quant, the three most recent readings for HCM's Common Equity are $1.3 billion (Q4 2025), $771.9 million (Q4 2024), and $743.4 million (Q4 2023).